The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally

[1]  D. Cunningham,et al.  Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  V. Thorsson,et al.  Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Itzkowitz,et al.  Low baseline awareness of gastric cancer risk factors amongst at-risk multiracial/ethnic populations in New York City: results of a targeted, culturally sensitive pilot gastric cancer community outreach program , 2020, Ethnicity & health.

[5]  D. Forman,et al.  Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035 , 2020, Gut.

[6]  G. Icaza,et al.  Gastric Cancer Mortality Trends in the Southern Cone: Disentangling age, period and cohort patterns in Argentina and Chile , 2020, Scientific Reports.

[7]  Joon-Oh Park,et al.  Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer , 2018, Nature Medicine.

[8]  P. Rosenberg,et al.  The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites , 2018, Journal of the National Cancer Institute.

[9]  S. Ng,et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.

[10]  J. Ajani,et al.  Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project , 2017, Clinical Cancer Research.

[11]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[12]  M. Rugge,et al.  Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial , 2017, JAMA oncology.

[13]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[14]  R. Malekzadeh,et al.  The stomach cancer pooling (StoP) project: study design and presentation , 2015, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[15]  M. Asaka,et al.  Strategies for eliminating death from gastric cancer in Japan , 2014, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[16]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[17]  C. Rabkin,et al.  The Problem of Helicobacter pylori Resistance to Antibiotics: A Systematic Review in Latin America , 2014, The American Journal of Gastroenterology.

[18]  Sharmila Anandasabapathy,et al.  Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[19]  Y. Bang,et al.  Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics , 2014, Asia-Pacific journal of clinical oncology.

[20]  F. Meneses-González,et al.  Risk factors for gastric cancer in Latin America: a meta-analysis , 2012, Cancer Causes & Control.

[21]  Syed Haider,et al.  International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data , 2011, Database J. Biol. Databases Curation.

[22]  Elias Campo Guerri,et al.  International network of cancer genome projects , 2010, Nature.

[23]  Gary D Bader,et al.  International network of cancer genome projects , 2010, Nature.

[24]  A. Norman,et al.  Capecitabine and oxaliplatin for advanced esophagogastric cancer. , 2008, The New England journal of medicine.

[25]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..